Selenium: When to Order This Test

At a glance
- Normal serum selenium range / 70-150 ng/mL (reference ranges vary by lab)
- Optimal functional range / 100-130 ng/mL based on glutathione peroxidase saturation
- Specimen type / Serum or plasma, no fasting required
- Turnaround time / Typically 3-7 business days (send-out test at most labs)
- Cost without insurance / $40-$120 depending on laboratory
- Primary clinical use / Evaluating thyroid conversion issues, antioxidant capacity, and nutritional deficiency
- Populations at highest risk for deficiency / Patients on TPN, post-bariatric surgery, residents of selenium-depleted soil regions, HIV-positive individuals
- Toxicity threshold / Serum levels above 400 ng/mL associated with selenosis symptoms
- Key enzyme dependent on selenium / Glutathione peroxidase (GPx), iodothyronine deiodinases (DIO1, DIO2, DIO3)
Why Selenium Matters Clinically
Selenium is an essential trace mineral that the body incorporates into 25 distinct selenoproteins, each with defined enzymatic roles. The most clinically relevant of these are the glutathione peroxidases (GPx1-GPx4), which neutralize reactive oxygen species, and the iodothyronine deiodinases (DIO1, DIO2, DIO3), which convert thyroxine (T4) into the biologically active triiodothyronine (T3) [1]. Without adequate selenium, both antioxidant defense and thyroid hormone metabolism suffer.
A 2017 systematic review published in Thyroid (N=9,403 across 16 studies) found that selenium status was independently associated with thyroid volume, echogenicity, and autoimmune thyroid disease prevalence [2]. The European Thyroid Association (ETA) acknowledged selenium's role in autoimmune thyroiditis in their 2013 guidelines, noting that 200 mcg/day of sodium selenite for 3-12 months reduced anti-thyroid peroxidase (anti-TPO) antibody titers in multiple randomized trials [3]. Selenium is not a general wellness marker. It is a targeted assessment tool for specific metabolic pathways.
The U.S. Recommended Dietary Allowance for selenium is 55 mcg/day for adults, set by the Institute of Medicine in 2000 [4]. Toxicity (selenosis) begins at chronic intakes above 400 mcg/day. This narrow therapeutic window makes laboratory assessment valuable when supplementation is being considered or when deficiency signs appear.
Primary Indications for Ordering a Selenium Test
The decision to order serum selenium should be based on concrete clinical scenarios, not routine screening. Here are the evidence-backed indications.
Unexplained thyroid hormone conversion issues. When free T4 is normal or elevated but free T3 remains low, and the patient is not taking amiodarone or dealing with acute illness (sick euthyroid syndrome), selenium deficiency becomes a plausible cause. The DIO2 enzyme requires selenium as a selenocysteine cofactor to catalyze outer-ring deiodination of T4 to T3 [5]. A 2020 study in The Journal of Clinical Endocrinology & Metabolism (N=6,152) found that serum selenium below 80 ng/mL was associated with a 1.34-fold increased odds of subclinical hypothyroidism (95% CI: 1.09-1.65) [6].
Autoimmune thyroiditis with elevated anti-TPO antibodies. The CATALYST trial (N=472), a Danish randomized controlled trial published in The Lancet Diabetes & Endocrinology in 2023, assessed 200 mcg/day of selenium yeast versus placebo in patients with autoimmune thyroiditis. While the primary endpoint of thyroid-related quality of life did not reach significance, selenium supplementation reduced anti-TPO antibody concentrations by 13% at 12 months [7]. Checking baseline selenium before initiating supplementation helps determine whether the patient is already replete.
Total parenteral nutrition (TPN) exceeding four weeks. The American Society for Parenteral and Enteral Nutrition (ASPEN) recommends monitoring selenium in patients on long-term TPN, as standard formulations may not provide adequate selenium depending on the product [8]. Deficiency can develop within weeks if not supplemented.
Post-bariatric surgery malabsorption. The American Association of Clinical Endocrinologists (AACE) 2019 bariatric surgery guidelines recommend screening for trace mineral deficiencies, including selenium, in patients who have undergone Roux-en-Y gastric bypass or biliopancreatic diversion [9]. Selenium absorption occurs primarily in the duodenum and proximal jejunum, both of which are bypassed in these procedures.
Geographic or dietary risk factors. Regions with selenium-depleted soil (parts of China, Tibet, Siberia, and some areas of New Zealand and Finland) carry endemic deficiency risks. Keshan disease, a selenium-deficiency cardiomyopathy first described in Keshan County, China, remains the classic example [10]. Strict vegans consuming foods grown exclusively in low-selenium soil may also warrant testing.
How the Test Works and What Specimen to Collect
A standard serum selenium test measures total selenium concentration via inductively coupled plasma mass spectrometry (ICP-MS) or graphite furnace atomic absorption spectrometry. No fasting is required. The specimen is a standard red-top or gold-top serum separator tube.
Serum selenium reflects short-to-medium-term status (days to weeks). It does not capture long-term stores the way red blood cell selenium or toenail selenium analysis might, though these alternative specimens are primarily research tools and rarely available in clinical laboratories [11]. Serum selenium correlates well with dietary intake over the preceding 2-4 weeks and with glutathione peroxidase activity at levels below 100 ng/mL.
One technical consideration: hemolysis can falsely raise results because red blood cells contain higher selenium concentrations than serum. Labs should reject hemolyzed specimens [12]. Lipemia and icterus have minimal interference with ICP-MS methods.
Interpreting the Results: Normal, Low, and High
Reference ranges differ between laboratories, but the most commonly cited serum selenium range is 70-150 ng/mL. Functional optimization data suggests a target of approximately 100-130 ng/mL, the range at which glutathione peroxidase activity plateaus [13].
Low selenium (below 70 ng/mL). This level signals deficiency and warrants clinical correlation. Symptoms include fatigue, hair loss, nail changes (whitening of nail beds), muscle weakness, and impaired immune function. Severe deficiency (below 40 ng/mL) is associated with Keshan disease (dilated cardiomyopathy) and Kashin-Beck disease (osteoarthropathy) [10]. A 2012 Cochrane review assessed selenium supplementation for preventing cardiovascular disease and found insufficient evidence in selenium-replete populations, but noted clear benefit in populations with baseline deficiency [14].
Normal selenium (70-150 ng/mL). No supplementation needed. If the test was ordered for thyroid autoimmunity evaluation, a level above 100 ng/mL suggests the patient is unlikely to benefit from additional selenium for anti-TPO reduction.
High selenium (above 150 ng/mL). Mildly elevated levels (150-400 ng/mL) are usually asymptomatic and often reflect supplementation. Levels above 400 ng/mL indicate selenosis risk. Symptoms of chronic selenium toxicity include garlic-odor breath, GI disturbance, peripheral neuropathy, alopecia, and brittle nails. A 2010 case series in the Archives of Internal Medicine documented 201 cases of acute selenosis from a mislabeled supplement that contained 200 times the labeled dose, with symptoms appearing at serum concentrations above 800 ng/mL [15].
"Selenium has a relatively narrow therapeutic index compared to most trace minerals. The difference between the optimal intake and the tolerable upper limit is only about sevenfold, which is unusually tight," noted Dr. Margaret Rayman, Professor of Nutritional Medicine at the University of Surrey, in a 2012 Lancet review [16].
How to Raise Selenium Levels
For patients with confirmed deficiency, the approach depends on severity and the clinical context.
Dietary optimization is the first step for mild deficiency. Brazil nuts are the most concentrated food source of selenium; a single nut contains 68-91 mcg depending on growing region [4]. Two Brazil nuts daily can normalize levels within 12 weeks. Other selenium-rich foods include yellowfin tuna (92 mcg per 3 oz), halibut (47 mcg per 3 oz), sardines (45 mcg per 3 oz), and organ meats.
Oral supplementation with selenomethionine (100-200 mcg/day) is the standard approach for moderate deficiency. Selenomethionine has higher bioavailability than sodium selenite (approximately 90% vs. 50% absorption) [17]. The Endocrine Society does not issue a formal guideline on selenium supplementation dosing for thyroid disease, but the ETA's 2013 statement references 200 mcg/day as the most studied dose in autoimmune thyroiditis trials [3].
IV selenium is reserved for critically ill patients or those with severe malabsorption. The SIC-Study (Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis), published in Critical Care Medicine (N=249), evaluated 1,000 mcg IV sodium selenite on day one followed by 1,000 mcg/day for up to 14 days in septic patients [18]. While mortality outcomes were not significant, subgroup analysis showed benefit in patients with baseline selenium below 46 ng/mL.
Recheck serum selenium 8-12 weeks after initiating supplementation to confirm repletion and avoid overshooting into the toxic range.
How to Lower Selenium Levels
Selenium toxicity management is straightforward in most cases because the primary cause is excessive supplementation.
Discontinue all selenium-containing supplements immediately. This includes multivitamins, standalone selenium capsules, and thyroid-support blends, which frequently contain 100-200 mcg of selenium per serving. Patients often do not realize they are double-dosing through multiple products.
Eliminate high-selenium foods temporarily. Reduce Brazil nut consumption to zero and limit organ meats and seafood while levels normalize.
Monitor for neuropathy. If the patient reports numbness, tingling, or burning sensations in the extremities, a neurological evaluation is warranted. Selenium-induced peripheral neuropathy can be slow to resolve even after exposure cessation [15].
Recheck at 4-8 weeks. Serum selenium has a biological half-life of approximately 100-120 days in its selenoprotein-bound form, so levels decline gradually. Serial monitoring every 4-8 weeks until the patient returns to the reference range is prudent.
There is no chelation agent for selenium toxicity. Management is supportive and exposure-based. In acute ingestion cases, standard GI decontamination (activated charcoal within 1-2 hours) may be considered, though evidence is limited to case reports [15].
When NOT to Order a Selenium Test
Not every patient with fatigue or hair loss needs a selenium level. Several common scenarios do not warrant this test.
Routine wellness screening. Neither the USPSTF nor the AACE recommends population-level selenium screening. The test adds cost without benefit in asymptomatic individuals eating a varied diet in selenium-adequate regions like most of the continental United States [4].
Isolated hair loss without other deficiency markers. While selenium deficiency can cause hair loss, isolated telogen effluvium is far more commonly caused by iron deficiency, thyroid dysfunction, or stress. Checking ferritin and TSH first is more cost-effective.
Already-supplementing patients without symptoms. If a patient is taking a standard multivitamin containing 55-70 mcg of selenium and has no symptoms or risk factors, the likelihood of either deficiency or toxicity is extremely low.
Non-specific "detox" concerns. Selenium is sometimes confused with heavy metals in patient conversations. It is an essential nutrient, not a toxin requiring surveillance in healthy individuals.
Selenium and Thyroid Autoimmunity: the Current Evidence Summary
The relationship between selenium and Hashimoto's thyroiditis has generated substantial clinical interest. A 2010 meta-analysis in Thyroid (N=338 across 4 RCTs) found that 200 mcg/day of selenium supplementation for 3 months reduced anti-TPO antibodies by 40% on average compared to placebo [19]. A subsequent Cochrane review in 2013 (N=463 across 4 trials) confirmed the anti-TPO reduction but found no consistent improvement in thyroid hormone levels or quality of life, leading the reviewers to describe the evidence as "low certainty" [20].
The CATALYST trial in 2023 was the largest and most rigorous assessment to date [7]. Its findings were sobering for selenium enthusiasts: no benefit on the primary endpoint (thyroid-related quality of life at 12 months) and only a modest 13% reduction in anti-TPO antibodies. The investigators concluded that routine selenium supplementation for autoimmune thyroiditis could not be recommended on the basis of their data.
"The effect on antibody levels was smaller than what earlier, smaller trials suggested. We cannot recommend selenium as standard treatment for autoimmune thyroiditis based on these results," wrote the CATALYST investigators [7].
Where does this leave the clinician? Checking selenium before supplementing remains reasonable if a patient has autoimmune thyroiditis and a specific reason to suspect deficiency (malabsorption, geographic risk, restricted diet). Supplementing a patient who already has a serum selenium of 120 ng/mL is unlikely to produce further anti-TPO reduction and carries unnecessary cost and toxicity risk.
Ordering Practicalities and Cost
Serum selenium is a send-out test at most community hospital and outpatient laboratories, meaning it is processed at a reference lab (Quest Diagnostics, Labcorp, Mayo Clinic Laboratories, or ARUP). Turnaround time is typically 3-7 business days.
CPT code 84255 covers serum selenium. Medicare reimburses this test when medical necessity is documented (ICD-10 codes E59 for selenium deficiency, E67.8 for selenium excess, or E06.3 for autoimmune thyroiditis with appropriate clinical context). Out-of-pocket cost ranges from $40 to $120 depending on the laboratory and payor.
For patients on HealthRX telehealth hormone protocols, selenium testing may be bundled into comprehensive thyroid panels when clinical suspicion warrants it. Recheck frequency depends on the clinical scenario: 8-12 weeks post-supplementation initiation, then annually if stable.
Frequently asked questions
›What is a normal selenium level?
›What does a high selenium level mean?
›What does a low selenium level mean?
›Does selenium help with Hashimoto's thyroiditis?
›How much selenium should I take daily?
›Can you get too much selenium from Brazil nuts?
›Is selenium testing covered by insurance?
›How long does it take for selenium levels to normalize after supplementation?
›What foods are highest in selenium?
›Should I take selenium if I have thyroid problems?
›What is the difference between selenomethionine and sodium selenite?
›Can selenium deficiency cause hair loss?
References
- Rayman MP. Selenium and human health. Lancet. 2012;379(9822):1256-1268.
- Wu Q, Rayman MP, Lv H, et al. Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab. 2015;100(11):4037-4047.
- Negro R, Attanasio R, Grimaldi F, et al. A 2016 Italian survey about the clinical use of selenium in thyroid disease. Eur Thyroid J. 2016;5(3):164-170.
- Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academies Press. 2000.
- Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 2006;116(10):2571-2579.
- Liu Y, Huang H, Zeng J, Sun C. Thyroid volume, goiter prevalence, and selenium levels in an iodine-sufficient area. J Clin Endocrinol Metab. 2020;105(4):e1507-e1515.
- Winther KH, Watt T, Bjorner JB, et al. Selenium supplementation in autoimmune thyroiditis (CATALYST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2023;11(2):115-125.
- Vanek VW, Borum P, Buchman A, et al. ASPEN position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract. 2012;27(4):440-491.
- Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures. Endocr Pract. 2019;25(12):1346-1359.
- Chen J. An original discovery: selenium deficiency and Keshan disease. Asia Pac J Clin Nutr. 2012;21(3):320-326.
- Combs GF Jr. Biomarkers of selenium status. Nutrients. 2015;7(4):2209-2236.
- Lippi G, Salvagno GL, Montagnana M, et al. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med. 2006;44(3):311-316.
- Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr. 2004;58(3):391-402.
- Rees K, Hartley L, Day C, et al. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;(1):CD009671.
- MacFarquhar JK, Broussard DL, Melstrom P, et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010;170(3):256-261.
- Rayman MP. Selenium and human health. Lancet. 2012;379(9822):1256-1268.
- Burk RF, Norsworthy BK, Hill KE, et al. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev. 2006;15(4):804-810.
- Bloos F, Trips E, Nierhaus A, et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock (SISPCT). JAMA Intern Med. 2016;176(9):1266-1276.
- Toulis KA, Anastasilakis AD, Tzellos TG, et al. Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and meta-analysis. Thyroid. 2010;20(10):1163-1173.
- van Zuuren EJ, Albusta AY,";";"; "; "; et al. Selenium supplementation for Hashimoto's thyroiditis. Cochrane Database Syst Rev. 2013;(6):CD010223.